The study, a world first in comprehensive next-generation ‘mapping’ of an entire prostate cancer genome, was performed using the Irys®System from Bionano Genomics, Inc.
It uncovered ten times more large-scale DNA rearrangements than have previously been detected in prostate cancer. Large-scale rearrangements can include relocation of long stretches of DNA from one part of the genome to another, as well as deletions or insertions of DNA sequence at particular sites in the genome.
Professor Vanessa Hayes, Head of Garvan’s Human Comparative and Prostate Cancer Genomics Laboratory, led the study.
…continue reading at the Garvan Institute of Medical Research website.
Acknowledgement: Content reproduced with permission from the Garvan Institute of Medical Research.